B CELL MALIGNANCIES
Clinical trials for B CELL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new B CELL MALIGNANCIES trials appear
Sign up with your email to follow new studies for B CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer patients get continued access to promising drug in rollover study
Disease control OngoingThis study offers continued treatment with the drug parsaclisib (alone or with other medicines) to people with B-cell cancers who were already benefiting from it in earlier studies. The main goal is to check safety and side effects. Participants must have stable disease and be to…
Matched conditions: B CELL MALIGNANCIES
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
New pill shows promise in early trial for blood cancers
Disease control OngoingThis early-stage study tests a new drug called ABBV-525 in people with B-cell cancers like lymphoma and leukemia. The goal is to find a safe dose and see if it can shrink tumors. About 78 adults will take the drug by mouth at different doses over several months.
Matched conditions: B CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Zanubrutinib extension study tracks Long-Term safety in blood cancer patients
Disease control OngoingThis study looks at the long-term safety of the drug zanubrutinib in people with B-cell cancers (a type of blood cancer) who were already in a related trial. About 955 participants will continue or start zanubrutinib and be monitored for side effects and how well the drug control…
Matched conditions: B CELL MALIGNANCIES
Phase: PHASE3 • Sponsor: BeiGene • Aim: Disease control
Last updated May 14, 2026 12:01 UTC